Nurix Therapeutics Inc [NRIX]
Pivot duomenys
Pivot statistika
| Rodiklis | Vidurkis | Mediana | Stand. nuokr. |
|---|---|---|---|
| Prieaugis % | 29.43% | 27.11% | 22.78% |
| Nuostolis % | -17.22% | -15.47% | 11.15% |
| Trukmė | 19.4d | 14d | 15.1d |
| Rasta pivot taškų | 46 |
| Prieaugio/nuostolio atkarpos | 45 (22 Prieaugis / 23 Nuostolis) |
| Paskutinis pivot | Top @ $17.12 data 2026-06-17 |
| Pokytis nuo paskutinio pivot | $0.00 (0.00%) |
Kito pivot prognozė Paskutinė: $17.12
| Prognozuojamas kitas tipas | Bottom |
| Prognozuojama kaina (vid.) | $14.17 |
| Prognozuojama kaina (mediana) | $14.47 |
| Prognozuojamas kainos intervalas (~68%) | $12.26 - $16.08 |
| Pokytis iki vidutinio tikslo | $-2.95 (-17.22%) |
| Prognozuojama data (vid.) | 2026-07-06 |
| Prognozuojamas datos intervalas (~68%) | 2026-06-21 - 2026-07-21 |
| Pagrindas | Based on 23 historical losses (Avg: -17.22%, Median: -15.47%, StdDev of Abs: 11.15%) and duration (Avg: 19.4 days, StdDev: 15.1 days) |
| Pastaba | Ranges assume ~normal distribution & historical patterns repeat. Use with caution. |
Nurix Therapeutics Inc edges higher, up 0.29%.
Nurix Therapeutics Inc (NRIX) stock price showed a minimal gain on Wednesday after the stock rose $0.0500 (0.29%) from the previous session on very low volume. The stock showed moderate relative strength, staying flat or rising slightly while the NASDAQ fell -1.34%.(The stock has risen 3 days straight. This extended rally increases the chances of a price pullback soon) With 2.12M shares traded, volume yesterday reached $36.38M. This was 550 800 shares less than the prior day. Compared to the 10-day average of 4.68M shares, volume was less than the average.
Nurix Therapeutics Inc signals
There is no conclusive signals given from RSI. The price is above both the short- and long-term averages, and the short-term average is above the long-term average, confirming an established up-trend. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (43.3%), medium- (43.3%), and long-term (43.3%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.
Nurix Therapeutics Inc Support & Resistance Levels
The stock is approaching the closest resistance level at $17.50. approximately $0.380 (2.22%) away. Approaching it. Breaking above this level could signal further upside where next resistance level will be found at $19. On a fall back there will be support at $15.6 The dis das resistance s115.6 -
Nurix Therapeutics Inc Evaluation
- Trumpas balas: 3.27
- Vidutinis balas: 4.85
- Ilgas balas: 4.58